Current alternative and complementary therapies used in menopause

被引:28
|
作者
Wong, Veronica Chi Ken [1 ,3 ]
Lim, Chi Eung Danforn [2 ,3 ]
Luo, Xiping
Wong, Wu Shun Felix [3 ,4 ]
机构
[1] Univ Western Sydney, Dept Complementary Med, Penrith, NSW 1797, Australia
[2] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia
[3] Univ New S Wales, Dept Obstet & Gynaecol, Liverpool Hosp, Fac Med, Sydney, NSW, Australia
[4] Univ New S Wales, Sch Womens & Childrens Hlth, Fac Med, Sydney, NSW, Australia
关键词
Menopause; hot flushes; symptom relief; review; complementary and alternative medicine; HOT FLASHES; DOUBLE-BLIND; BREAST-CANCER; POSTMENOPAUSAL WOMEN; BLACK COHOSH; VASOMOTOR SYMPTOMS; RED-CLOVER; CIMICIFUGA-RACEMOSA; REPLACEMENT THERAPY; SOY PROTEIN;
D O I
10.1080/09513590802549866
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine the efficacy and safety of common complementary and alternative medicine (CAM) therapies used to relieve the menopausal symptoms. Design. Comprehensive literature search was conducted through the databases Medline, EMBASE, Cochrane, AMED (Allied and Complementary Medicine), NCCAM (The National Centre for Complementary and Alternative Medicine) to identify relevant monographs in English language. Results. Studies have shown that some therapies such as clonidine, selective serotonin receptor inhibitors (SSRIs) and gabapentin are effective in decreasing the degree and frequency of somatic symptoms in menopause, while phytooestrogens and black cohosh have shown mixed results. Use of Ginseng, evening primrose, Dong Quai or vitamin E appears not to be efficacious for the relieving hot flushes. Other effects of these therapies including possible improvements in mood are yet to be substantiated. Inclusion criteria. All available human complementary medicine studies on menopausal women with regard to the relief of menopausal symptoms. Exclusion criteria. Studies not meeting the inclusion criteria, published in languages other than English or animal studies. Conclusion. There is a general lacking of longer-term follow-up beyond the trial lengths of 6-12 weeks in the use of CAM, although women may be taking these medications for many years. Well-designed, randomised control trials are needed to elucidate the true effect of these therapies above the placebo effect.
引用
收藏
页码:166 / 174
页数:9
相关论文
共 50 条